BPMC
Price
$128.35
Change
+$0.15 (+0.12%)
Updated
Jul 3 closing price
Capitalization
8.29B
23 days until earnings call
KTTA
Price
$0.73
Change
-$0.02 (-2.67%)
Updated
Jul 3 closing price
Capitalization
5.45M
Interact to see
Advertisement

BPMC vs KTTA

Header iconBPMC vs KTTA Comparison
Open Charts BPMC vs KTTABanner chart's image
Blueprint Medicines
Price$128.35
Change+$0.15 (+0.12%)
Volume$1.35M
Capitalization8.29B
Pasithea Therapeutics
Price$0.73
Change-$0.02 (-2.67%)
Volume$67.1K
Capitalization5.45M
BPMC vs KTTA Comparison Chart in %
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. KTTA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Hold and KTTA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (BPMC: $128.35 vs. KTTA: $0.73)
Brand notoriety: BPMC and KTTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 37% vs. KTTA: 1%
Market capitalization -- BPMC: $8.29B vs. KTTA: $5.45M
BPMC [@Biotechnology] is valued at $8.29B. KTTA’s [@Biotechnology] market capitalization is $5.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileKTTA’s FA Score has 1 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • KTTA’s FA Score: 1 green, 4 red.
According to our system of comparison, BPMC is a better buy in the long-term than KTTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 3 TA indicator(s) are bullish while KTTA’s TA Score has 5 bullish TA indicator(s).

  • BPMC’s TA Score: 3 bullish, 5 bearish.
  • KTTA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KTTA is a better buy in the short-term than BPMC.

Price Growth

BPMC (@Biotechnology) experienced а +0.16% price change this week, while KTTA (@Biotechnology) price change was -0.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.59%. For the same industry, the average monthly price growth was +13.92%, and the average quarterly price growth was -0.53%.

Reported Earning Dates

BPMC is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+5.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($8.29B) has a higher market cap than KTTA($5.45M). BPMC YTD gains are higher at: 47.157 vs. KTTA (-76.756). KTTA has higher annual earnings (EBITDA): -13.24M vs. BPMC (-66.42M). BPMC has more cash in the bank: 576M vs. KTTA (5.34M). KTTA has less debt than BPMC: KTTA (0) vs BPMC (467M). BPMC has higher revenues than KTTA: BPMC (562M) vs KTTA (0).
BPMCKTTABPMC / KTTA
Capitalization8.29B5.45M152,092%
EBITDA-66.42M-13.24M502%
Gain YTD47.157-76.756-61%
P/E RatioN/AN/A-
Revenue562M0-
Total Cash576M5.34M10,784%
Total Debt467M0-
FUNDAMENTALS RATINGS
BPMC: Fundamental Ratings
BPMC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
54
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BPMCKTTA
RSI
ODDS (%)
Bearish Trend 5 days ago
75%
Bullish Trend 5 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
83%
Bullish Trend 5 days ago
78%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bearish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
69%
Bullish Trend 5 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
75%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
71%
Bearish Trend 5 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
71%
Declines
ODDS (%)
Bearish Trend 11 days ago
73%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
65%
Bullish Trend 5 days ago
79%
Aroon
ODDS (%)
Bullish Trend 5 days ago
65%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KTTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPT3.41N/A
N/A
Opthea Limited
UTHR294.49-0.73
-0.25%
United Therapeutics Corp
CMPR49.68-0.20
-0.40%
Cimpress plc
XYLO4.98-0.05
-1.07%
Xylo Technologies Ltd
XBIT3.18-0.04
-1.24%
XBiotech

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
+0.12%
KYMR - BPMC
49%
Loosely correlated
+0.58%
VERA - BPMC
47%
Loosely correlated
N/A
NRIX - BPMC
45%
Loosely correlated
+2.33%
APLS - BPMC
44%
Loosely correlated
+2.47%
IDYA - BPMC
43%
Loosely correlated
+0.82%
More

KTTA and

Correlation & Price change

A.I.dvisor tells us that KTTA and INCY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KTTA and INCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KTTA
1D Price
Change %
KTTA100%
-2.09%
INCY - KTTA
28%
Poorly correlated
+0.41%
SCNI - KTTA
26%
Poorly correlated
-2.95%
GNFT - KTTA
22%
Poorly correlated
+2.11%
TRAW - KTTA
22%
Poorly correlated
-0.68%
BPMC - KTTA
21%
Poorly correlated
+0.12%
More